drugset / Trial / NCT00762476
Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses
Phase 2
Completed
411 enrolled
The Dial Corporation
Hill Top Research · collabTKL Research, Inc. · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy of 3804-250A in the prevention of the common cold. The study will also evaluate whether 3804-250A prevents rhinovirus infection, a virus that causes many common colds.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-11
- Completion
- 2008-11
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Placebo vs 3804-250A; p >0.5000; Poisson regression NCT00762476 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 3804-250A | Unknown | 2 unknown | Topical |